The move, announced earlier this year by the Seattle biopharmaceutical company (NASDAQ: CTIC), will save $14 million annually.

• 这一举措，今年初宣布的在西雅图的生物制药公司（纳斯达克股票代码： CTIC ） ，将节省一千四点零万美元每年。